A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- NON RANDOMIZED · PARALLEL · SUPPORTIVE CARE · NONE
- Evidence population
- Human clinical study registration
- Participants
- 42
- Population
- ALL · 65 Years
- Duration
- 2021-10-29 to 2025-05-31
- Intervention
- Pharmacist-Led Optimization Intervention
- Comparator
- Control; Active Decliners
- Outcomes measured
- Proportion of subjects who Achieve Glycosylated Hemoglobin (HbA1c) values — Month 6; Change in HbA1c — From Baseline through Month 6; Random Glucose Measurements — From Baseline through Month 12; Estimated Change in Out-of-Pocket Costs — From Baseline through Month 6; Point estimates of Feasibility Measures: Participation/Reach — Month 6; Point estimates of Feasibility Measures: Number Contacted/Reach — Month 6; Point estimates of Feasibility Measures: Number at Risk/Reach — Month 6; Feasibility Measures: Effort Required to Enroll-Number Calls — Month 6; Feasibility Measures: Effort Required to Enroll-Average Call Duration — Month 6; Point estimates of Feasibility Measure-Number of Visits — Month 12; Point estimates of Feasibility Measures: Time — Month 12; Rate of Emergency Department Visits and Hospitalizations — Baseline through Month 18; Number of Hypoglycemic Events Requiring Medical Assistance — Time Frame: Baseline through Month 18; Number of Injurious Falls — Baseline through Month 18; Mortality — Baseline through Month 18; Implementation Metric--Feasibility — Baseline through Month 18; Implementation Metric-- Acceptability — Baseline through Month 18; Implementation Metric-- Appropriateness — Baseline through Month 18; Implementation Metric- Value — Baseline through Month 18
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 80% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Frailty · 80%Title contains controlled term: frailty, frailty index. Title supplies longevity context: frailty, frail. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.